Abstract:Recently, the original paper entitled “Notch3 deficiency impairs coronary microvascular maturation and reduces cardiac recovery after myocardial ischemia” reported by Yong-Kang Tao and colleagues attracted our interest [ [1] Tao Y.K. Zeng H. Zhang G.Q. Chen S.T. Xie X.J. He X. et al. Notch3 deficiency impairs coronary microvascular maturation and reduces cardiac recovery after myocardial ischemia. Int. J. Cardiol. 2017; 236: 413-422 Abstract Full Text Full Text PDF PubMed Scopus (16) Google Scholar ]. Their results revealed that Notch3 deficiency reduced cardiac pericyte coverage, impaired coronary blood flow reserve, and ultimately increased ischemic area post myocardial infarction (MI) via inhibiting CXCR4/SDF-1α and VEGF/Ang-1 signaling pathways [ [1] Tao Y.K. Zeng H. Zhang G.Q. Chen S.T. Xie X.J. He X. et al. Notch3 deficiency impairs coronary microvascular maturation and reduces cardiac recovery after myocardial ischemia. Int. J. Cardiol. 2017; 236: 413-422 Abstract Full Text Full Text PDF PubMed Scopus (16) Google Scholar ]. Therefore, Notch3 might be a novel therapeutic approach to MI centered at increasing pericyte/progenitor cell recruitment and vascular maturation. Cardiac fibrosis which is characterized by excessive deposition of scar tissue significantly reduces cardiac function after MI [ [2] Leask A. Potential therapeutic targets for cardiac fibrosis: TGFbeta, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation. Circ. Res. 2010; 106: 1675-1680 Crossref PubMed Scopus (549) Google Scholar ]. Thus, anti-fibrotic therapy is promising in curbing fibrosis and enhancing cardiac function after MI [ [3] Sassoli C. Chellini F. Pini A. Tani A. Nistri S. Nosi D. et al. Relaxin prevents cardiac fibroblast-myofibroblast transition via notch-1-mediated inhibition of TGF-beta/Smad3 signaling. PLoS One. 2013; 8e63896 Crossref PubMed Scopus (111) Google Scholar ]. Zhang et al. demonstrated that Notch3 inhibited cardiac fibroblast-myofibroblast transition in MI mice and in cultured CFs with TGF-β1 stimulus by inhibiting TGF-β1/Smad3 signaling pathway to reduce cardiac fibrosis [ [4] Zhang M. Pan X. Zou Q. Xia Y. Chen J. Hao Q. et al. Notch3 ameliorates cardiac fibrosis after myocardial infarction by inhibiting the TGF-beta1/Smad3 pathway. Cardiovasc. Toxicol. 2016; 16: 316-324 Crossref PubMed Scopus (35) Google Scholar ]. Zhang et al. also reported that Oncostatin M (OSM) significantly alleviated cardiac ischemia/reperfusion (I/R) injury via Notch3/Akt signaling pathway. OSM receptor Oβ knockout also promoted cardiomyocyte apoptosis, impaired mitochondrial function, exacerbated I/R injury, and inhibited Notch3 production. However, Notch3 overexpression alleviated, while Notch3 siRNA treatment aggravated cardiac I/R injury in mice [ [5] Zhang M. Wang C. Hu J. Lin J. Zhao Z. Shen M. et al. Notch3/Akt signaling contributes to OSM-induced protection against cardiac ischemia/reperfusion injury. Apoptosis. 2015; 20: 1150-1163 Crossref PubMed Scopus (26) Google Scholar ]. Collectively, these findings supported that Notch3 is a potential therapeutic target for ischemic heart diseases by promoting pericyte/progenitor cell recruitment and vascular maturation, inhibiting cardiac fibrosis, improving mitochondrial function, and alleviating cardiac dysfunction. Notch3 deficiency impairs coronary microvascular maturation and reduces cardiac recovery after myocardial ischemiaInternational Journal of CardiologyVol. 236PreviewVascular maturation plays an important role in wound repair post-myocardial infarction (MI). The Notch3 is critical for pericyte recruitment and vascular maturation during embryonic development. Full-Text PDF

Notch1 protects against myocardial ischaemia-reperfusion injury via regulating mitochondrial fusion and function

Notch1 provides myocardial protection by improving mitochondrial quality control

Notch1 Protects Against Ischemic-Reperfusion Injury by Suppressing PTEN-Pink1-Mediated Mitochondrial Dysfunction and Mitophagy

Notch1 Cardioprotection in Myocardial Ischemia/reperfusion Involves Reduction of Oxidative/nitrative Stress

Cardioprotective Actions of Notch1 Against Myocardial Infarction Via LKB1-dependent AMPK Signaling Pathway

[The Effect of Notch1 on Myocardial Ischemia Reperfusion Injury].

Notch 1 Signalling Inhibits Cardiomyocyte Apoptosis in Ischaemic Postconditioning

Abstract 12099: Activated Notch1 Interacting with LKB1 Reduces Myocardial Ischemic Injury Via Modulating AMPK Signaling Pathway

Notch Signaling Activation Contributes to Cardioprotection Provided by Ischemic Preconditioning and Postconditioning.

Activated Notch1 reduces myocardial ischemia reperfusion injury in vitro during ischemic postconditioning by crosstalk with the RISK signaling pathway.

Notch1-Nrf2 signaling crosstalk provides myocardial protection by reducing ROS formation

Notch1 Signaling Activation Protected Myocardium Against Hypoxia Injury Via Reducing Programmed Cell Death.

Notch Signaling Promotes Angiogenesis and Improves Cardiac Function after Myocardial Infarction

Protective Effects Of Notch1 Signaling Activation Against High Glucose-Induced Myocardial Cell Injury: Analysis Of Its Mechanisms Of Action

Keap-NRF2 Signaling Contributes to the Notch1 Protected Heart Against Ischemic Reperfusion Injury Via Regulating Mitochondrial ROS Generation and Bioenergetics

B-type Natriuretic Peptide Protect Cardiomyocytes at Reperfusion Via Mitochondrial Calcium Uniporter

Notch1 Signaling Modulates Neuronal Progenitor Activity in the Subventricular Zone in Response to Aging and Focal Ischemia

New role of Notch-mediated signaling pathway in myocardial ischemic preconditioning.

A Potential and Novel Therapeutic Approach to Ischemic Heart Diseases: Notch3.

DUSP1 Alleviates Cardiac Ischemia/reperfusion Injury by Suppressing the Mff-required Mitochondrial Fission and Bnip3-related Mitophagy Via the JNK Pathways

Activation of Notch1 Pathway Alleviated Myocardial Ischemia/reperfusion Injury induced by High Temperature and Humidity through Promoting Autophagy